InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.07
(
0.90%
)
US TECH 100
19,480.00
(
1.12%
)
Dow Jones
42,352.75
(
0.81%
)
Brent Oil
77.97
(
0.00%
)
Bitcoin
62,027.24
(
-0.08%
)
Post# of 7234
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mw2006tn

Send PM Follow Ignore
Followers 1
Posts 515
Boards Moderated 0
Alias Born 11/15/2006

mw2006tn

Re: B_roke post# 1905

Thursday, 05/07/2009 10:03:54 AM

Thursday, May 07, 2009 10:03:54 AM

Post# of 7234
Lot's of long term potential...

From page 2 of...
http://www.rttnews.com/ArticleView.aspx?Id=939795&SMap=1&pageNum=2745_4020_2

"On April 14, Cell Therapeutics announced that it began a rolling submission of a New Drug Application to the FDA for Pixantrone. The company has also planned to request priority review for the drug. If a priority review is granted, the FDA's decision on the drug can be expected in the fourth-quarter of 2009. Pixantrone is now available through a named-patient program in Europe. If approved, the company expects Pixantrone sales to reach $1 billion by 2014."


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up